mci 9038 has been researched along with Glioma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heth, J; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Tang, L; Xi, G | 1 |
Knovich, MA; Lesser, GJ; Strowd, RE | 1 |
Hoff, JT; Hua, Y; Keep, RF; Schallert, T; Xi, G | 1 |
Fewel, ME; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Schallert, T; Tang, L; Xi, G | 1 |
Fewel, ME; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Schallert, T; Tang, LL; Xi, GH | 1 |
5 other study(ies) available for mci 9038 and Glioma
Article | Year |
---|---|
Thrombin enhances glioma growth.
Topics: Animals; Anticoagulants; Arginine; Behavior, Animal; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Glioma; Hemostatics; Male; Neoplasm Transplantation; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Tetrazolium Salts; Thiazoles; Thrombin; Time Factors | 2008 |
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2012 |
A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model.
Topics: Animals; Antithrombins; Arginine; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Glioma; Immunohistochemistry; Nervous System Diseases; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Thrombin | 2003 |
The role of thrombin in gliomas.
Topics: Animals; Arginine; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Glioma; Humans; Male; Motor Activity; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Survival Rate; Thrombin; Tumor Burden | 2005 |
Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models.
Topics: Animals; Anticoagulants; Antineoplastic Agents; Arginine; Brain; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Injections, Intraventricular; Male; Mental Disorders; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Survival Rate; Treatment Outcome | 2005 |